Japan Fertility Services Market Research Report By Underlying Cause (Male Infertility, Female Infertility) and By Treatment Type (ART, Infertility Drugs)-Forecast to 2035.
ID: MRFR/HC/43237-HCR | 200 Pages | Author: Rahul Gotadki| April 2025
As per MRFR analysis, the Japan Fertility Services Market Size was estimated at 1.16 (USD Billion) in 2023. The Japan Fertility Services Market Industry is expected to grow from 1.29(USD Billion) in 2024 to 3.87 (USD Billion) by 2035. The Japan Fertility Services Market CAGR (growth rate) is expected to be around 10.503% during the forecast period (2025 - 2035).
Key Japan Fertility Services Market Trends Highlighted
A confluence of social, economic, and technical variables is now driving notable developments in the Japanese fertility services business. The aging of first-time moms, which is mostly caused by changing social standards around family planning, work, and education, is a major market driver. In Japan, a lot of women prioritize their personal growth and jobs, which results in later pregnancies. In order to address the issues of diminishing fertility rates, this trend has led to an increase in demand for comprehensive fertility treatments and assisted reproductive technologies (ART). Innovative reproductive therapies and improved medical facilities have been more common in Japan in recent years. The nation is concentrating on making reproductive services more affordable and accessible.
Furthermore, new potential to increase the success rates of fertility treatments is being created by technological breakthroughs like AI-powered platforms for customized treatment programs and enhanced embryo selection procedures. Opportunities include the possibility of growing support networks for infertile couples, such as counselling and complementary therapies. The industry is also anticipated to benefit from the Japanese government's efforts to promote childbearing through financial incentives and supporting laws. Investors and healthcare providers should look at forming partnerships to provide more individualized care options and creative solutions catered to the particular requirements of Japanese families, given the country's robust healthcare infrastructure and dedication to health innovation.
A greater readiness to seek aid may result from a growing understanding and acceptance of reproductive services as society's attitudes regarding them continue to change. In order to provide a supportive atmosphere for individuals and couples navigating their reproductive journeys in Japan, public awareness campaigns on fertility challenges and accessible therapies are essential.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Japan Fertility Services Market Drivers
Increasing Prevalence of Infertility
The rising rates of infertility in Japan are driving the Japan Fertility Services Market Industry significantly. According to the Japan Society of Obstetrics and Gynecology, approximately 1 in 6 couples in Japan face difficulties in conceiving, which translates to around 15% of the reproductive-age population. This alarming statistic is a key factor contributing to the increasing demand for fertility services. The aging population in Japan, where women are choosing to have children later in life, further exacerbates the issue as fertility rates decline with age.With the government pushing for policies to support family formation, including financial assistance programs for couples undergoing fertility treatments, there is a more robust ecosystem promoting the Japan Fertility Services Market. Organizations such as the Japan Association of Clinical Embryologists are actively involved in educating the public and promoting advancements in fertility treatments, further supporting market growth.
Advancements in Fertility Treatments
Technological advancements in fertility treatments are significantly enhancing the Japan Fertility Services Market Industry. Innovative procedures such as In Vitro Fertilization (IVF), Preimplantation Genetic Testing (PGT), and the use of artificial intelligence in clinical settings have improved success rates for couples seeking assistance. The Ministry of Health, Labour, and Welfare in Japan has recognized over 30,000 IVF cycles annually, signifying the growing trust in these advanced procedures.Furthermore, the introduction of novel techniques and tailored treatment plans continues to attract couples who may have previously been discouraged due to low success rates. Institutions like the Japanese Society for Reproductive Medicine are playing a pivotal role by providing certifications and promoting best practices that ensure high-quality care in fertility clinics, thus positively influencing market growth.
Government Support and Health Policies
The Japanese government has begun to recognize the importance of addressing infertility through supportive health policies. Initiatives such as subsidies for fertility treatments and coverage through public insurance are incentivizing couples to seek professional fertility services. In recent years, financial support has been expanded to include IVF treatments, with funding allocated nearing 60 billion yen to help couples facing infertility challenges.This robust governmental framework and commitment to reducing the financial burden on couples has made the Japan Fertility Services Market Industry more accessible and is expected to bolster its growth. Organizations like the Japan Fertility Association are advocating for continued governmental support and awareness, creating a comprehensive approach to fertility issues within the country.
Rising Awareness and Acceptance of Fertility Services
There is a growing societal acceptance of infertility treatments in Japan, leading to increased demand in the Japan Fertility Services Market Industry. Ongoing educational campaigns by medical organizations and media outlets are helping to dispel myths and raise awareness about fertility issues. Data from recent surveys indicated that over 70% of the population now recognizes infertility as a medical condition requiring attention, compared to just 50% a decade ago.Organizations such as the Japan Society of Fertility and Sterility are crucial in changing perceptions and facilitating educational outreach, thus encouraging couples to take proactive approaches toward their fertility health. As awareness increases, it is anticipated that more individuals will seek these services, further propelling the market.
Japan Fertility Services Market Segment Insights
Fertility Services Market Underlying Cause Insights
The Japan Fertility Services Market, with a significant focus on underlying causes, is increasingly capturing attention as more couples face challenges related to infertility. Within this framework, both Male Infertility and Female Infertility emerge as prominent categories, each contributing distinct dynamics to the market's growth. Male infertility is increasingly recognized due to factors such as lifestyle changes, environmental influences, and health issues, which collectively contribute to a noticeable rise in diagnoses. In contrast, female infertility factors often relate to advanced maternal age, hormonal imbalances, and medical conditions such as polycystic ovary syndrome (PCOS), making awareness and treatment essential.
The increasing prevalence of these underlying causes underscores the importance of tailored fertility services, leading to growth in specialized clinics and innovative treatments. Moreover, advancements in assisted reproductive technologies are crucial for addressing the unique challenges faced in both categories. While existing cultural perceptions may influence steps taken toward treatment, there is a growing acceptance of seeking medical assistance, further driving patient engagement in the Japan Fertility Services Market. Overall, the rapid evolution and increased focus on fertility options, driven by changing societal norms and medical advancements, signify a transformative period for those grappling with infertility issues.
Japan’s healthcare policies also reflect a responsive approach to addressing infertility, providing a conducive environment for the growth of fertility services. As awareness continues to broaden, both Male Infertility and Female Infertility are set to dominate industry discussions in Japan, shaping the future of fertility treatments.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Fertility Services Market Treatment Type Insights
The Treatment Type segment of the Japan Fertility Services Market is characterized by a diverse range of options, with Assisted Reproductive Technology (ART) and Infertility Drugs being prominent components. ART, including procedures such as in vitro fertilization (IVF), has gained significant traction in recent years, responding to increasing infertility rates attributed to various factors, including late marriages and lifestyle choices. This method is critical as it facilitates conception for couples facing difficulties, thereby significantly impacting the Japan Fertility Services Market revenue.
Infertility Drugs also play a crucial role in this landscape; they are essential for stimulating ovulation and enhancing fertility chances, which makes them a vital consideration for many seeking to expand their families. The growing awareness and acceptance of these treatments, coupled with advancements in reproductive technologies and medical research, create continuous opportunities in this sector.
Challenges such as regulatory approvals and the high cost of treatments remain, yet the increasing societal acceptance of fertility services underpins a burgeoning industry poised for growth, supported by favorable demographics and evolving healthcare policies.Furthermore, the Japan Fertility Services Market statistics indicate a trend toward more personalized patient care, with declining stigma surrounding fertility treatments leading to higher demand across the market.
Japan Fertility Services Market Key Players and Competitive Insights
The Japan Fertility Services Market is experiencing significant growth, driven by a combination of increasing infertility rates, advancements in reproductive technologies, and a growing acceptance of assisted reproductive techniques. As the demand for fertility services rises, numerous players are entering the market, creating a highly competitive landscape characterized by innovation, partnerships, and expanding service offerings. Companies in this sector are striving to enhance patient experiences, improve treatment outcomes, and broaden their reach to cater to a diverse patient demographic.
The presence of both private and public entities, along with the integration of cutting-edge technology into treatment protocols, is reshaping the dynamics of fertility services, making it essential for market participants to adopt strategic approaches to differentiate themselves.Adena Health has established a notable presence in the Japan Fertility Services Market, leveraging its extensive network and advanced medical technologies to deliver high-quality fertility treatments. The company focuses on providing comprehensive fertility services ranging from artificial insemination to in-vitro fertilization, with a particular emphasis on personalized care. Adena Health's strengths in this competitive landscape lie in its well-trained medical staff, strong patient support systems, and commitment to research and development, positioning it as a trusted provider within Japan. The company's facilities are equipped with state-of-the-art laboratories and technology, further enhancing its capability to deliver successful treatment outcomes while maintaining a strong reputation in patient satisfaction.
Nihon University plays a crucial role in the Japan Fertility Services Market through its commitment to education, research, and clinical practice in reproductive health. As an academic institution, it offers specialized training programs for healthcare professionals interested in fertility services, thereby ensuring a steady influx of skilled practitioners into the market. Nihon University's strengths lie in its comprehensive research initiatives focused on reproductive health and its longstanding partnerships with various healthcare organizations. The university is engaged in various key projects and initiatives that explore innovative fertility treatments and the underlying biology of infertility.
Through its clinical services, Nihon University provides a range of fertility treatments, including assisted reproductive technologies, gynecological consultations, and fertility preservation. The institution's emphasis on research collaborations and potential partnerships enhances its market presence, allowing it to contribute significantly to advancements in the field while serving as a leading educational and clinical entity in Japan's fertility landscape.
Key Companies in the Japan Fertility Services Market Include
Japan Fertility Services Market Industry Developments
Recent developments in the Japan Fertility Services Market indicate a growing interest in improving reproductive healthcare services. In October 2023, Adena Health announced advancements in fertility treatment methodologies, emphasizing personalized care for patients seeking assistance. Nihon University and Rikkyo University continue their joint research into reproductive health, focusing on enhancing success rates with innovative techniques. Kinki University Hospital and Juntendo University have recently expanded their fertility health programs, which include state-of-the-art technologies and research collaborations. Moreover, in August 2023, a strategic alliance was formed between Mitsubishi Chemical Holdings Corporation and various universities, aiming to develop new biomaterials for reproductive applications. The expansion of facilities and services is reflected in the overall growth in market valuation, which has seen increased investments in recent years.
The Fertility Specialists Medical Group is also working to improve accessibility to treatments. Notably, in July 2022, Kumamoto University established a dedicated fertility research center to address the rising need for fertility preservation among young cancer patients. This heightened focus on fertility services highlights the urgent need to adapt to changing demographics and societal expectations regarding family planning in Japan.
Japan Fertility Services Market Segmentation Insights
Fertility Services Market Underlying Cause Outlook
Male Infertility
Female Infertility
Fertility Services Market Treatment Type Outlook
ART
Infertility Drugs
Report Attribute/Metric Source: | Details |
MARKET SIZE 2018 | 1.16(USD Billion) |
MARKET SIZE 2024 | 1.29(USD Billion) |
MARKET SIZE 2035 | 3.87(USD Billion) |
COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.503% (2025 - 2035) |
REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
BASE YEAR | 2024 |
MARKET FORECAST PERIOD | 2025 - 2035 |
HISTORICAL DATA | 2019 - 2024 |
MARKET FORECAST UNITS | USD Billion |
KEY COMPANIES PROFILED | Adena Health, Nihon University, Rikkyo University, Kinki University Hospital, Mitsubishi Chemical Holdings Corporation, Juntendo University, Miyazaki Medical College, Kumamoto University, Osaka University Hospital, Shiga University of Medical Science, Kanazawa University, Miyoshi Biomedia, Keio University Hospital, Fertility Specialists Medical Group |
SEGMENTS COVERED | Underlying Cause, Treatment Type |
KEY MARKET OPPORTUNITIES | Rising infertility rates, Advanced reproductive technologies, Growing demand for egg freezing, Increased awareness of fertility options, Supportive government policies and funding |
KEY MARKET DYNAMICS | Aging population, Rising infertility rates, Increasing awareness, Advanced reproductive technologies, Government support initiatives |
COUNTRIES COVERED | Japan |
Frequently Asked Questions (FAQ) :
The Japan Fertility Services Market is expected to be valued at 1.29 billion USD in 2024.
By 2035, the Japan Fertility Services Market is projected to reach a value of 3.87 billion USD.
The expected CAGR for the Japan Fertility Services Market from 2025 to 2035 is 10.503%.
The male infertility segment is expected to be valued at 1.19 billion USD by 2035.
The female infertility segment is anticipated to reach a value of 2.68 billion USD in 2035.
Major players in the market include Adena Health, Nihon University, Rikkyo University, and Mitsubishi Chemical Holdings Corporation.
Growth drivers include increasing awareness about fertility issues and advancements in reproductive technologies.
Challenges may include regulatory hurdles and the high cost of fertility treatments.
Regional availability of advanced healthcare infrastructure influences the adoption of fertility services significantly.
Key applications include assisted reproductive technologies, such as in vitro fertilization and artificial insemination.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)